Association mapping of the PARK10 region for Parkinson's disease susceptibility genes.

@article{Wan2014AssociationMO,
  title={Association mapping of the PARK10 region for Parkinson's disease susceptibility genes.},
  author={J. Y. Wan and K. Edwards and C. Hutter and I. F. Mata and A. Samii and John W. Roberts and P. Agarwal and H. Checkoway and F. Farin and D. Yearout and C. Zabetian},
  journal={Parkinsonism & related disorders},
  year={2014},
  volume={20 1},
  pages={
          93-8
        }
}
  • J. Y. Wan, K. Edwards, +8 authors C. Zabetian
  • Published 2014
  • Biology, Medicine
  • Parkinsonism & related disorders
    • BACKGROUND Previous studies indicate that as many as six genes within the PARK10 region (RNF11, UQCRH, HIVEP3, EIF2B3, USP24, ELAVL4) might modify susceptibility or age at onset in Parkinson's disease (PD). METHODS We sought to identify new PD susceptibility genes and to validate previously nominated candidate genes within the PARK10 region using a two-stage design. We used data from a large, publicly-available genome-wide association study (GWAS) in the discovery stage (n = 2000 cases and… CONTINUE READING
    View on PubMed
    europepmc.org
    14 Citations
    Background Citations
    3
    14 Citations
    Citation Type

    Citation Type

    The association between CD157/BST1 polymorphisms and the susceptibility of Parkinson’s disease: a meta-analysis
    • 3
    • PDF
    Variation in PARK10 is not associated with risk and age at onset of Parkinson's disease in large clinical cohorts
    • 6
    Advances in understanding genomic markers and pharmacogenetics of Parkinson’s disease
    • 22
    TCEANC2 rs10788972 and rs12046178 variants in the PARK10 region in Chinese Han patients with sporadic Parkinson's disease
    • 10
    Parkinson’s Disease Genes VPS35 and EIF4G1 Interact Genetically and Converge on α-Synuclein
    • 93
    Mechanisms Implicated in Parkinson Disease from Genetic Perspective
    • 7
    Genetic Variants of Microtubule Actin Cross-linking Factor 1 (MACF1) Confer Risk for Parkinson’s Disease
    • 19
    Neural ablation of the PARK10 candidate Plpp3 leads to dopaminergic transmission deficits without neurodegeneration
    • 6
    • PDF
    G2019S Mutation of LRRK2 Increases Autophagy via MEK/ERK Pathway
    • 2
    Clinical Trials In Parkinson's Disease

    References

    SHOWING 1-10 OF 29 REFERENCES
    Identification of risk and age-at-onset genes on chromosome 1p in Parkinson disease.
    • 66
    Genomic convergence to identify candidate genes for Parkinson disease: SAGE analysis of the substantia nigra
    • 48
    Genomewide association study for susceptibility genes contributing to familial Parkinson disease
    • 404
    Genomewide association study for onset age in Parkinson disease
    • 95
    • PDF
    Genome-Wide Association Study reveals genetic risk underlying Parkinson’s disease
    • 1,526
    • PDF
    Genetic evidence for ubiquitin‐specific proteases USP24 and USP40 as candidate genes for late‐onset Parkinson disease
    • 44
    Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson’s disease
    • 576
    • PDF
    Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population.
    • 149
    • PDF
    Replication of association between ELAVL4 and Parkinson disease: the GenePD study
    • 33
    Genome-wide association study confirms extant PD risk loci among the Dutch
    • 147
    • PDF